Skip to content

Musculoskeletal ultrasound evaluation of the clinical efficacy of Tuina combined with the "Theory of the Origin of Diseases" in the treatment of cervical cervical spondylosis

Explore musculoskeletal ultrasound to evaluate the clinical efficacy of Tuina combined with the "Theory of Origin of Diseases" in the treatment of cervical cervical spondylosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072648
Enrollment
Unknown
Registered
2023-06-20
Start date
2023-06-20
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis

Interventions

Control group :conventional Tuina treatment
Experimental group :Tuina combined with neck transport three-method treatment

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria (1) Meet the diagnostic criteria for cervical spondylosis, male or female; (2) Age 18-60 years old; (3) Subjects who voluntarily participate in clinical trials and sign informed consent. If any of the above answers are "no", the subject cannot participate in this trial.

Exclusion criteria

Exclusion criteria: (2) Exclusion criteria (1) Other types of cervical spondylosis; (2) Neck sprain, periarthritis of the shoulder, rheumatic myofibrositis, neurasthenia and other neck and shoulder pain not caused by cervical disc degeneration. (3) pregnant or planning to become pregnant, lactating women; (4) Those with allergies, sensitive skin or weak bodies; (5) Serious liver, kidney, hematopoietic system, endocrine system diseases, osteoporosis, malignant tumors, severe trauma, myocardial infarction, cerebral hemorrhage sequelae and other serious primary diseases, psychotic patients, and serious infections; (6) Those with cognitive dysfunction or communication impairment who cannot cooperate with the completion of scales, treatment or follow-up. (7) Participants in other clinical trials. If any of the above answers are "yes", this subject cannot participate in this trial.

Design outcomes

Primary

MeasureTime frame
McGill Pain Scale;Neck disability index (NDI);Morphological measurement of musculoskeletal ultrasound posterior cervical extensor group;Evaluation of symptomatic efficacy;

Secondary

MeasureTime frame
Follow-up observation;

Countries

China

Contacts

Public ContactQu Jianpeng

Zhejiang Hospital

qjp0007@126.com+86 180 7282 6239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026